Stock Analiz

Novavax Inc. (NVAX) stock forecast and price target

Price $8.53 · data as of November 13, 2026

12-month price target

Average target$14.11
Upside / downside+65.5%
Analysts9
ConsensusBuy
Low $7.00Average $14.11High $25.00

Gold marker: average target · white marker: today’s price ($8.53)

Analyst ratings

Strong buy 0Buy 5Hold 1Sell 1Strong sell 2

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.05−102.5%$473M
Next fiscal year
ends December 31, 2027
$-0.45−125.0%$246M
Next quarter
ends December 31, 2026
$0.54+341.8%$216M
Quarter after
ends March 31, 2027
$-0.35—$36M

Consensus of the analysts covering Novavax, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Novavax stock price target?

The average 12-month target from 9 analysts is $14.11, 65.5% above the current price of $8.53 Targets range from $7.00 to $25.00.

Is Novavax a buy according to analysts?

The consensus rating is “Buy” (5 buy, 1 hold, 1 sell, 2 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Novavax expected to earn?

Analysts expect EPS of $-0.05 for the fiscal year ending December 31, 2026 and $-0.45 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.